Reality and Truth Balancing the Hope and the Hype of Real-World Evidence

被引：10
|
作者：
Patel, Anushka [1 ]
Billot, Laurent [1 ]
机构：
[1] Univ New South Wales, George Inst Global Hlth, Sydney, NSW, Australia
来源：
CIRCULATION | 2017年 / 136卷 / 03期
关键词：
Editorials; causality; clinical trial; diabetes mellitus; observational study; SGLT proteins; CARDIOVASCULAR OUTCOMES; CARE; QUALITY;
D O I：
10.1161/CIRCULATIONAHA.117.029233
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：260 / 262
页数：3
相关论文
共 50 条
  • [21] PEER-REVIEWED JOURNAL EDITORS' VIEWS ON REAL-WORLD EVIDENCE
    Oehrlein, Elisabeth M.
    Graff, Jennifer S.
    Perfetto, Eleanor M.
    Mullins, C. Daniel
    Dubois, Robert W.
    Anyanwu, Chinenye
    Onukwugha, Eberechukwu
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2018, 34 (01) : 111 - 119
  • [22] Real-world evidence study on the early use of cemiplimab in the UK: REACT-CEMI (Real World evidence of advanced CSCC treatment with cemiplimab)
    Challapalli, Amarnath
    Stewart, Grant
    Shaw, Heather
    Davies, Peter John
    Lopez-Baez, Juan Carlos
    Ottley, Edward C.
    Kelly, Stephen
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [23] Organic generation of real-world real-time data for clinical evidence in radiation oncology
    Bertolet, A.
    Wals, A.
    Miras, H.
    Macias, J.
    INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS, 2020, 144
  • [24] Biases in Electronic Health Records Data for Generating Real-World Evidence: An Overview
    Al-Sahab, Ban
    Leviton, Alan
    Loddenkemper, Tobias
    Paneth, Nigel
    Zhang, Bo
    JOURNAL OF HEALTHCARE INFORMATICS RESEARCH, 2024, 8 (01) : 121 - 139
  • [25] Real-World Evidence to Assess Medication Safety or Effectiveness in Children: Systematic Review
    Lasky, Tamar
    Carleton, Bruce
    Horton, Daniel B.
    Kelly, Lauren E.
    Bennett, Dimitri
    Czaja, Angela S.
    Gifkins, Dina
    Osokogu, Osemeke U.
    McMahon, Ann W.
    DRUGS-REAL WORLD OUTCOMES, 2020, 7 (02) : 97 - 107
  • [26] Real-world costs of chronic lymphocytic leukaemia in the Netherlands
    Holtzer-Goor, K. M.
    Bouwmans-Frijters, C. A. M.
    Schaafsma, M. R.
    de Weerdtc, O.
    Joosten, P.
    Posthuma, E. F. M.
    Wittebol, S.
    Huijgens, P. C.
    Matthssen, E. J. M.
    Vreugdenhil, G.
    Visser, H.
    Peters, W. G.
    Erjavec, Z.
    Wijermans, P. W.
    Daenen, S. M. G. J.
    van der Hem, K. G.
    van Oers, M. H. J.
    Uyl-de Groot, C. A.
    LEUKEMIA RESEARCH, 2014, 38 (01) : 84 - 90
  • [27] Be-All End-All Real-World Evidence on the Subcutaneous ICD
    Al-Khatib, Sana M.
    Kusumoto, Fred M.
    CIRCULATION, 2021, 143 (01) : 18 - 20
  • [28] Advancing the Real-World Evidence for Medical Devices through Coordinated Registry Networks
    Sedrakyan, Art
    Marinac-Dabic, Danica
    Campbell, Bruce
    Aryal, Suvekshya
    Baird, Courtney E.
    Goodney, Philip
    Cronenwett, Jack L.
    Beck, Adam W.
    Paxton, Elizabeth W.
    Hu, Jim
    Brindis, Ralph
    Baskin, Kevin
    Cowley, Terrie
    Levy, Jeffery
    Liebeskind, David S.
    Poulose, Benjamin K.
    Rardin, Charles R.
    Resnic, Frederic S.
    Tcheng, James
    Fisher, Benjamin
    Viviano, Charles
    Devlin, Vincent
    Sheldon, Murray
    Eldrup-Jorgensen, Jens
    Berlin, Jesse A.
    Drozda, Joseph
    Matheny, Michael E.
    Dhruva, Sanket S.
    Feeney, Timothy
    Mitchell, Kristi
    Pappas, Gregory
    BMJ SURGERY INTERVENTIONS & HEALTH TECHNOLOGIES, 2022, 4
  • [29] Rationale, Strengths, and Limitations of Real-World Evidence in Oncology: A Canadian Review and Perspective
    Azoulay, Laurent
    ONCOLOGIST, 2022, 27 (09) : E731 - E738
  • [30] Real-world evidence: How pragmatic are randomized controlled trials labeled as pragmatic?
    Dal-Re, Rafael
    Janiaud, Perrine
    Ioannidis, John P. A.
    BMC MEDICINE, 2018, 16
12345